Why the study?
Atrial fibrillation is a major risk factor for stroke, and the effects of apixaban on clot microstructure using gel point analysis remained to be characterized.
Does apixaban alter clot microstructure and clotting kinetics in patients with atrial fibrillation?
Does apixaban alter clot microstructure and clotting kinetics in patients with atrial fibrillation?
Apixaban prolongs clotting time without altering clot stability in AF patients, suggesting it protects against thrombus formation by reducing clotting kinetics.
Answers are grounded in this paper and cite their sources.
Apixaban-associated TGP prolongation without df change should not yet change AF practice; leaves open mechanistic effects on thrombus risk.
Atrial fibrillation (AF) is a major risk factor for stroke. We aim to characterize AF patients and the effects of apixaban therapy in terms of clot microstructure using gel point analysis, a novel biomarker. Seventy‐eight patients were included in the study, 50 Stroke with AF (AF‐S), and 28 AF without stroke (AF). Pre‐ and post‐anticoagulation samples were collected: gel point (GP) analysis was performed to obtain (i) TGP (the time taken to reach the GP or the clot formation time) and (ii) d f , the fractal dimension of the clot, a quantification of clot fibrin microstructure at the GP. At baseline, the AF‐S group had a d f = 1.70 (±0.05) and TGP = 306 (±73 s). The AF group had a df = 1.70 ± 0.05 and TGP = 346 ± 78 s, showing a significantly shortened TGP in the stroke group ( p = .008). For both groups, apixaban significantly prolonged TGP, p = .005, but resulted in no change in df. Apixaban prolonged clotting time while having no significant impact on the blood’s ability to form stable clots (no change in d f ). This indicates that apixaban provides protection from the formation of thrombi by reducing clotting kinetics.
No takes yet. Share an insight, caveat, or question.
Lawrence et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: